83570-42-7

Basic information

• Product Name: Ethanone, 1-(6-quinoxalinyl)- (9CI)
• Synonyms: Ethanone, 1-(6-quinoxalinyl)- (9CI);1-(Quinoxalin-6-yl)ethanone;Ethanone, 1-(6-quinoxalinyl)-
• CAS NO: 83570-42-7
• Molecular Formula: C10H8N2O
• Molecular Weight: 172.18332
• Product Categories: QUINOXALINE
• Mol File: 83570-42-7.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Ethanone, 1-(6-quinoxalinyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(6-quinoxalinyl)- (9CI)(83570-42-7)
• EPA Substance Registry System: Ethanone, 1-(6-quinoxalinyl)- (9CI)(83570-42-7)

Safety Data

• Hazardous Substances Data: 83570-42-7(Hazardous Substances Data)

Usage

General Description

Ethanone, 1-(6-quinoxalinyl)- (9CI) is a chemical compound that belongs to the ketone class. It is also known as 6-Quinoxalinyl methyl ketone and has the molecular formula C11H8N2O. Ethanone, 1-(6-quinoxalinyl)- (9CI) is used in various fields such as pharmaceuticals, agriculture, and research due to its unique properties and potential applications. It is important to handle this chemical with caution, as it can be hazardous if not properly managed. Its precise uses and properties depend on the specific application and the context in which it is being used.

Upstream product

• 131543-46-9 Glyoxal 
• 21304-39-2 1-(3,4-diaminophenyl)ethanone 
• 50998-17-9 6-bromoquinoxaline 
• 111-34-2 -butyl vinyl ether 
• 6925-00-4 quinoxaline-6-carboxylic acid 
• 875558-38-6 N-methoxy-N-methylquinoxaline-6-carboxamide 
• 75-16-1 methylmagnesium bromide 
• 97674-02-7 tributyl(1-ethoxyvinyl)stannane 
• 1432-42-4 1-(4-amino-3-nitrophenyl)ethanone 

Downstream Products

• 874279-36-4 1-(quinoxalin-6-yl)ethan-1-ol 

Relevant articles and documents

TETRAHYDRO-BENZOAZEPINE GLYCOSIDASE INHIBITORS

Compounds of formula (I') wherein A, R1, R2, T1, T2, T3, T4, L, W, Z, R''', m and n have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

Meta C-H Arylation of Electron-Rich Arenes: Reversing the Conventional Site Selectivity

Controlling site selectivity of C-H activation without using a directing group remains a significant challenge. While Pd(II) catalysts modulated by a mutually repulsive pyridine-type ligand have been shown to favor the relatively electron-rich carbon centers of arenes, reversing the selectivity to favor palladation at the relatively electron-deficient positions has not been possible. Herein we report the first catalytic system that effectively performs meta C-H arylation of a variety of alkoxy aromatics including 2,3-dihydrobenzofuran and chromane with exclusive meta site selectivity, thus reversing the conventional site selectivity governed by native electronic effects. The identification of an effective ligand and modified norbornene (NBE-CO2Me), as well as taking advantage of the statistics, are essential for achieving the exclusive meta selectivity.

LINEAR GLYCOSIDASE INHIBITORS

Compounds of formula (I) wherein A, R, W, Q, L, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.